Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Sleep Wake Disorders · Sleep Disorders, Circadian Rhythm · Chronobiology Disorders

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Vanda Investigational Site, Los Angeles, California, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Redwood City, California, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Aurora, Colorado, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Boston, Massachusetts, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, St Louis, Missouri, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, New Hyde Park, New York, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Cincinnati, Ohio, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Cleveland, Ohio, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Columbia, South Carolina, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, San Antonio, Texas, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Sherman, Texas, United States

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Innsbruck, Austria

  • Vanda Investigational Site, Vienna, Austria

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Berlin, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Hamburg, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Marburg, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400
  • Vanda Investigational Site, Schwerin, Germany

    Contact: Study coordinator (Vanda Pharmaceuticals Inc.) · 202-734-3400